Purpose: Congenital achromatopsia or rod monochromatism is a rare autosomal recessive condition defined by a severe loss of cone photoreceptor function in which rods purportedly retain normal or near-to-normal function. This report describes the results of electroretinography in two siblings with CNGB3-associated achromatopsia.
Introduction
Complete achromatopsia (ACHM), also known as rod monochromacy, is a rare autosomal recessive congenital condition with a prevalence of 1:30,000, characterised by complete or partial loss of cone function [1] . Clinically, patients present with photophobia, nystagmus, severely reduced visual acuity (20/200) and severe colour vision deficits [2] . Currently, six genes have been implicated in the generation of this disease, all of which encode crucial steps in the cone photo-transduction cycle. Two genes encoding for the cyclic nucleotide gated (CNG) channels alpha (α) and beta (β) (CNGA3, CNGB3) account for approximately 25% and 60% of the all mutations, respectively, with the rarer mutations found in the GNAT2, PDE6C, PDE6H, ATF6 genes [1, 3] . Over 140 mutations have been discovered in the CNGA3 and CNGB3 genes, most of which result in a failure to produce α or β subunits.
In the normal functioning retina the CNG channels, located in the plasma membrane of the outer segment, are held open in darkness by cyclic guanosine monophosphate (cGMP), creating an inward positive current. When light causes hydrolysis of cGMP the channels are closed causing a hyperpolarisation of the cell; without functional subunits, CNG channels remain constantly closed, preventing cone hyperpolarisation. In adults this can frequently result in the degeneration of cone photoreceptors. However, evidence of foveal disruption and hypoplasia has also been shown in young children [4 -7] . In a few cases, some residual cones may remain, although they too may later progressively decline [7] [8] [9] .
In the light of the above findings, the canonical view of congenital ACHM has been that it is a condition that primarily leads to cone dysfunction, leaving rod photoreceptoral function largely intact [1, 2, [10] [11] [12] [13] [14] [15] [16] [17] . However, the phenotype is highly variable and a growing body of experimental evidence indicates that ACHM may not only lead to structural and functional abnormalities within the cone photoreceptor population, but also may affect rod function as well. Rod dysfunction in ACHM, as assessed using ERG, has been noted in several studies, typically ranging from a mild [6, [18] [19] [20] [21] [22] ] to a moderate reduction in the rod ERG amplitude [23] [24] [25] . This can make discrimination between achromatopsia and cone-rod dystrophy (CORD) more difficult. Previously, the understanding was that the former was typically a stationary disease, associated with a normal rod ERG, whereas the latter was progressive in nature, affecting both rods and cones [26] . An additional confounding factor is that both CNGA3 and CNGB3 genes have been implicated in autosomal recessive cone rod dystrophy (arCORD) [23] [24] [25] [26] [27] [28] . In addition, structural changes more frequently associated with CORD, such as macular atrophy, have been reported in achromatopsia [14, 22] . In essence, the changes in amplitude noted to the rod ERG in achromatopsia generally remain in the sub-normal to moderate category compared to severely reduced or abolished rod response found in CORD [12, 25] .
In this report we present electro-retinographic results from two siblings with a homozygous 1148delC (Thr383fs) mutation in CNGB3. Interestingly, both of these siblings exhibit ERG findings which show severe disruption of the rod system, specifically confined to the inner retina, resulting in an electronegative ERG. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Materials and Methods

Participants and clinical assessment
Two siblings from a consanguineous Pakistani family living in the UK, both with molecularly confirmed CNGB3-associated ACHM were examined (see table 1 for a summary of the main features). In brief, the patients were first examined at 1 year of age presenting with the classical features of ACHM -congenital nystagmus, reduced vision and photophobia. Over three decades changes in visual function have been minimal, with VA having remained constant. The most significant changes have been structural with progressive macular atrophy being noted on successive retinal examinations. The patients do not report any symptoms of nyctalopia and prefer conditions of low illumination.
At the time of this study the patients were 31 yrs (Px1) and 38 yrs (Px 2) old and full clinical history and assessment of the participants was performed which included Snellen visual acuity, colour vision testing using the Colour Assessment and Diagnosis (CAD) Test (City University, London), as well as Ocular Coherence Tomography (OCT). In addition, Goldmann visual fields (Haag Streit, Bern, Switzerland) were assessed using the largest target on both ACHM patients (see figure 1 ). The subjects gave informed consent prior to the commencement of the experiments and the study was conducted using a process that had been approved by the Leeds Research Ethics Committee and met the tenets of the Helsinki declaration. 
Genetic Assessment
One of the siblings (Patient 1) had previously been recruited to an earlier study investigating the molecular genetic basis for inherited retinal disease (IRD). As part of this study, patients' DNA was analysed by Sanger sequencing of genes known at that time to be associated with ACHM in a step-by-step procedure. The proband was found to be homozygous for a null allele in CNGB3 (NM_019098.4; c.1148delC, p.T383Ifs*13), the most frequently reported cause of ACHM in those of European ancestry [29] . Segregation analysis confirmed that Patient 2 was also homozygous for the c.1148delC allele.
Electrophysiological Assessment
Full-field ERGs were recorded using a ColorDome (Diagnosys LLC, Lowell, MA, USA) four primary ganzfeld stimulator and were obtained using standard protocols detailed by the International Society for Clinical Electrophysiology of Vision (ISCEV) [30] . ISCEV stimuli we also examined rod mediated ERGs in our patient group and an agematched control using series of stimuli that varied over a wider range (~ 6 log units) of retinal illuminance from -1.9 -3.6 log scotopic trolands. ERGs were recorded using these stimuli which consisted of brief (4ms) white flashes delivered after 20 mins of dark adaptation.
ERGs were recorded from the right eye using a silver/nylon corneal fibre electrode (Dept. of
Physics and Clinical Engineering, Royal Liverpool University Hospital, UK) referenced to a 9mm Ag/AgCl electrode (Biosense Medical, Chelmsford, UK) on the outer canthus; a similar electrode was placed on the forehead to serve as ground. Impedance was maintained below which amplified and filtered (bandwidth = 1 to 300 Hz) the ERGs and digitised them at a rate of 1000Hz. Participants viewed the stimuli monocularly with a dilated pupil (1% Tropicamide). Table 2 here smaller reduction is noted in a-wave amplitude which may be explained by the loss of input from the dark adapted cone system [31] . Implicit times of the a-and b-waves are also increased compared to normative data (see table 2 ). Figure 3 shows the ERG waveforms for dark adapted ERGs recorded as a function of retinal illuminance across a 6 log unit scale (-1.9 -3.6 log scot trolands). The data show clear In particular, the electronegative appearance of the dark-adapted ERGs to more intense stimuli is a previously unreported finding for this specific mutation.
Figure 2 and
Figure 3 here
Rod function was assessed using standard ISCEV protocols. The dark-adapted (DA) rod stimulus (0.01 cd/s/m 2 ) elicits an ERG in the normal population that is typically dominated by a large positive component (the b-wave) with a peak occurring at approximately 100 ms after stimulus onset. This response reflects the activity of rod ON-bipolar cells from the inner nuclear layer of the retina [34, 35] . As the intensity of the stimulus is increased, the b-wave is preceded by a negative a-wave in the dark-adapted ERG, which predominantly reflects activity in the outer segments of the rod photoreceptors [31, 35] . The data presented here show that patients with CNGB3 associated achromatopsia have significant functional abnormalities in their rod system which accompanies severe cone dysfunction. This rod dysfunction is in the ACHM patients is manifest in the severely attenuated b-wave amplitudes of the dark adapted ERGs. In comparison, the a-waves of these responses are [31, 35] ), on the whole, a-wave amplitudes in the ACHM patients are comparable to normals. This differential effect on the b-and a-waves has not previously been reported and is significant because it points to a post-receptoral, inner retinal origin for this loss of rod function. It suggests that the deficit is at the level of the rod ON-bipolar cells, rather than at the level of the rod photoreceptors.
The reasons for the deficits in rod-mediated retinal function are not entirely clear. It is unlikely to be simply an age-related loss of rod function. The ages of the two ACHM patients in this study fall well within the range of previous study [5] where the ACHM patient cohort exhibits milder rod deficits than those reported here. Furthermore, the study by Moskowitz and colleagues [24] report rod deficits in a much younger group (median age 2.7 yrs) of ACHM patients. Genetic testing for the patients examined in this study was performed by successive Sanger sequencing of the following genes until a cause was identified (CNGA3, CNGB3, GNAT2, PDE6C). There remains the slim possibility that the family also segregate another monogenic retinopathy. However, the fact that the ERG shows a near normal awave with more severe b-wave reduction, specifically suggests a predominantly inner retina dysfunction, which is not a classical feature associated with cone-rod dystrophy. A more likely explanation is that the environment created by degenerating cones may play a part in the generation of dysfunction in rod-mediated vision. Macular atrophy was an acquired feature in both patients suggesting there is some outer retinal degeneration at the macula and supporting the idea that rod dysfunction may be a secondary feature of cone death. In addition, work in mouse models has shown significant correlations between cone cell death and CNG channel abnormalities. A recent review of cone cell death in achromatopsia [36] has outlined several mechanisms that may contribute to cone apoptosis; stress markers associated with the endoplasmic reticulum are increased in CNGA3 -/-and CNGA3 -/-knockout shown to increase endoplasmic reticulum stress [37] .
Recent advances in adaptive optics have made it possible to examine the structure of the both inner and outer segments of the photoreceptor layer in vivo using adaptive optics scanning laser ophthalmoscopy (AOSLO) [38, 39] . Imaging in patients with ACHM has shown significant loss and disruption of cone photoreceptors, but no real evidence of a decrease in the number of rods [5, 7] . However, changes in rod structure have been observed. Typically, the diameter of a rod photoreceptor in a healthy retina at 10 o eccentricity is approximately 2.3µm. Measurements of rod diameter in patients with ACHM in a similar region were shown to be on average 1µm greater [4] . This increase in diameter may be as a direct result of increased space in the retina which allows rods to expand following the loss of cone cells [24] . Increases in rod diameter naturally occur in the ageing retina as the overall number of rod cells is reduced [40] . It has been suggested that structural changes like these may well result in an alteration of the photo-transduction process and even post-receptoral connections [24] .
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